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Background: Acute respiratory tract infections are an important public health problem. Sensitive and rapid
diagnostic techniques have been developed and are used in daily clinical practice. Here we evaluate the clinical
relevance of detecting 20 common respiratory pathogens by molecular methods in a general pediatric clinic.
Methods: Nasopharynx samples of children < 18 years of age with respiratory symptoms referred to a general
pediatric clinic were tested for the presence of 19 viruses and Mycoplasma pneumoniae, using real-time polymerase
chain reaction.
Results: Of 177 patients included in this retrospective study, 73% were positive for at least one virus. Respiratory
syncytial virus (36.6%) and human rhinovirus (24%) were most frequently detected. Patients in whom a respiratory
virus or Mycoplasma pneumoniae was detected, were younger (6 versus 24 months; p < 0.001) and more often
hospitalized (116 versus 34; p = 0.001) than patients in whom no respiratory pathogen was detected. Also they
were more likely to present with feeding problems, dyspnea, rhinorrhea and wheezing (all p < 0.05) than patients
without a respiratory pathogen.
In the majority of cases, clinicians did not change their antibiotic management after detecting a viral respiratory
pathogen. No difference in mean Ct value was found between patients with one respiratory pathogen and those
with >1 respiratory pathogen (30.5 versus 31.2; p = 0.573).
Conclusion: Routine testing of common respiratory pathogens could lead to a better understanding of their role in
disease in children with respiratory symptoms.
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Acute respiratory tract infections (ARTIs) are a signifi-
cant cause of morbidity and account for a major per-
centage of mortality in early childhood worldwide.
Though ARTIs can be caused by bacteria and fungi, viral
infections seem to be responsible for most infections. In-
fluenza A and B virus (FLUAV, FLUBV), respiratory syn-
cytial virus (RSV), human parainfluenza viruses (HPIVs)
and adenovirus (HAdV) are well recognized respiratory
pathogens that account for 35% to 87% of ARTIs in chil-
dren and cannot be distinguished on the basis of clinical
presentation and symptoms [1-5].
Over the past two decades, molecular diagnostic tech-
niques for the detection of respiratory pathogens have* Correspondence: i.huijskens@gmail.com
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reproduction in any medium, provided the orbeen developed, providing rapid results with an
increased sensitivity [3,4,6]. In addition, these new tech-
niques contributed to the discovery of novel viruses such
as the human metapneumovirus (HMPV) [7], SARS cor-
onavirus [8], coronaviruses (HCoV) NL63 [9] and HKU1
[10], human bocavirus (HBoV) [11] and the recently
described KI and WU polyomaviruses (KIPyV, WUPyV)
[12,13]. In this study we tried to evaluate the clinical epi-
demiologic features of detecting 20 common respiratory
pathogens, 19 viruses and Mycoplasma pneumoniae, in
children attending a general pediatric clinic and the in-
fluence of their detection in clinical decision making.Materials and methods
Study design and subjects
The study was conducted in St. Elisabeth Hospital, one
of the largest non-university teaching hospitals in Theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sented with signs and symptoms of upper or lower re-
spiratory tract infection (RTI) (rhinorrhea, dyspnea,
cough, apnea, wheezing, tachypnea, etc.) at the hospital
emergency department, the pediatric outpatient clinic or
admitted to the pediatric ward between January 2010
through December 2010 and in whom a nasopharyx
sample was collected for respiratory virus and M. pneu-
moniae detection were included. Based on the Dutch
health system, the majority of pediatric patients who
visit the hospital are referred by their family doctor.
Only a minority of patients who visit the emergency de-
partment are not referred.
Relevant demographic and clinical data were extracted
from hospital charts using standardized case record
forms. Data collected included age, gender, underlying
medical conditions, use of antibiotics prior to admission,
use of antibiotics at admission, signs and symptoms at
presentation, findings on physical examination, oxygen
requirement, rate and duration of hospitalization, inten-
sive care unit admission, complications, bacterial cul-
tures and definitive clinical diagnosis.
Ethical considerations
Both the data collection and analyses were conducted in
a retrospective fashion from coded hospital medical
records, for which according to the Dutch Medical Re-
search Involving Human Subjects Act (article 1, para-
graph 1, section b of the WMO) no medical ethics
review was required. This was confirmed by our institu-
tional Ethics Review Board when we sought approval.
The need for subject or parental informed consent was
thus waived. To guarantee the privacy of study patients
we coded all tested isolates according to the require-
ments of the National Privacy Regulations in The
Netherlands.
Molecular detection of respiratory pathogens
All nasopharynx samples were tested with reverse tran-
scriptase (RT) real-time PCR [(RT)-qPCR] using parallelTable 1 Demographic characteristics by number of respirator
0 1
Number of patients (%) 47 (26.5) 83 (46.9)
Median age (months, range) 24 (0–192) 4 (0–153)
Male (%) 20 (42.6) 46 (55.4)
Underlying medical conditions (%) 13 (27.7) 17 (20.5)
Supplemental oxygen requirement (%) 8 (17.4) 31 (37.3)
Intensive care unit admission (%) 1 (2.1) 3 (3.6)
Mean duration of hospitalization (days) 4.0 5.5
Prematurity (%) 6 (12.8) 16 (19.3)qPCR assays for the following combinations of respira-
tory pathogens: 1) FLUAV/FLUBV, 2) RSV, 3) HPIV-(1–
4), 4) HMPV/ human rhinovirus (HRV), 5) HCoV-
HKU/NL63/OC43/229E, 6) HAdV, 7) HBoV, 8) KIPyV/
WUPyV, 9) human enterovirus (HEV)/human parecho-
virus (HPeV), 10) M. pneumoniae. (RT)-qPCR proce-
dures were performed as described previously [6,14,15].
All samples had been spiked before extraction with in-
ternal control viruses, Phocine Herpes Virus (PhHV;
DNA virus), and Phocine Distemper Virus (PDV; RNA
virus) to monitor efficient extraction and amplification.
For each target a positive and negative control was used.
(RT)-qPCR results were expressed in cycle threshold
(Ct) values. Ct values are inversely correlated with viral
load, i.e., low Ct values indicate high viral loads.
Statistical analysis
Comparison among groups was performed using a chi-
square test for categorical variables and for continuous
variables a t-test or Mann–Whitney test was used with a
significance level of p < 0.05. Ct values of each virus were
compared between the various groups using a t-test.
Whenever a given virus was not detected by (RT)-qPCR,
the corresponding viral load was assigned a value of
zero. Statistical analyses were conducted using PASW
Statistics 18 (IBM Company, Chicago, VS).
Results
A total of 177 nasopharynx specimens of 177 patients
were collected and analyzed. Ninety-eight (55.4%)
patients were males and 79 (44.6%) were females. The
median age was 8 months (range 3 days to 16 years).
Thirty-five (19.8%) children had an underlying medical
condition. Demographic characteristics of the patients
are presented in Table 1.
Etiology
At least one respiratory virus or M. pneumoniae was
detected in 130 (73.4%) respiratory samples. Significantly
more viruses were found in male (n = 78; 60.0%) than iny pathogens detected
Number of pathogens detected
2 3 4 Total pathogens
38 (21.5) 8 (4.5) 1 (0.6) 177 (100)
7 (1–77) 14 (2–52) 9 8 (0–192)
27 (71.1) 5 (62.5) 0 (0) 98 (55.4)
4 (10.5) 1 (12.5) 0 (0) 35 (19.8)
14 (36.8) 5 (62.5) 0 (0) 58 (33.0)
1 (2.6) 0 (0) 0 (0) 5 (2.8)
3.0 4.8 0 4.5
3 (7.9) 1 (12.5) 0 (0) 26 (14.7)
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FLUAV and HPIV-2, all other respiratory viruses and M.
pneumoniae were detected. Most commonly detected
were RSV in 64 (36.6%) and HRV in 42 (24.1%) samples.
The detection rates of the other viruses were HEV in
8.5%, WUPyV in 5.6%, HPIV-1 in 5.1%, HAdV and
HBoV in 4.5%, HCoV-OC43 in 4.0%, HPIV-3 in 2.8%,
HPeV 2.3%, HCoV-HKU1, HMPV and M. pneumoniae
in 1.7%, FLUBV in 1.1% of the samples, respectively. The
detection rates for HCoV-NL63, HCoV-229E, KIPyV and
HPIV-4 were <1%.
Seasonality of respiratory virus infection
There was variability in seasonal detection of respiratory
pathogens (Figure 1). RSV, the most detected virus, was
found only between November and February, with a
peak in December and January. HRV, the second most
detected virus, was present during the entire year with
two small peaks, one in January and the other in October/
November. HEV and WUPyV were also detected through-
out the year. Of the HPIVs, HPIV-1 was the most frequent
detected virus and detected throughout the year.























Figure 1 Seasonality of respiratory pathogens. Abbreviations: HAdV: hu
(HKU1, NL63, OC43 and 229E), HEV: human enterovirus, HMPV: human met
KI polyomavirus, MP: Mycoplasma pneumoniae, HPIV 1–4: human parainflue
respiratory syncytial virus and WUPyV: WU polyomavirus.being the most frequent coronavirus, only detected in
November and December. HPeV, HMPV, FLUBV,
KIPyV and M. pneumoniae were sporadically detected
in this study.
Co-detection of respiratory pathogens
In total, 184 viruses and 3M. pneumoniae were detected.
Forty-seven (26.6%) respiratory samples had multiple (> 1)
respiratory viruses; 38 (21.5%) samples contained 2 respira-
tory viruses, 8 (4.5%) samples contained 3 viruses, 1 sample
contained 2 viruses and M. pneumoniae, and 1 respiratory
sample contained 4 respiratory viruses. RSV and HRV were
found in 27 (57.4%) and 28 (59.6%) of the 47 respiratory
samples with multiple respiratory pathogens viruses,
respectively and RSV and HRV were 12 (25.5%) times
co-detected with each other. HCoV-HKU1, HCoV-229E,
FLUBV and KIPyV were always co-detected.
Ct value
Overall, Ct values between patients in whom only one
respiratory pathogen was detected, and patients with > 1
pathogen did not differ significantly (30.5 versus 31.2;




















man adenovirus, HBoV: human bocavirus, HCoV: human coronaviruses
apneumovirus, FLUAV: influenza A virus, FLUBV: influenza B virus, KIPyV:
nza viruses, HPeV: human parechovirus, HRV: human rhinovirus, RSV:
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value for 36 single virus infections was 28.3 and 27.8 for 28
multiple virus infections (p = 0.74). For HRV the mean Ct
value for 15 single virus infections was 30.7 and 31.4 for 27
multiple virus infections (p = 0.76). For HEV the mean Ct
value for 6 single virus infections was 33.9 and 27.3 for 9
multiple virus infections (p = 0.057).
Patients
Patients in whom respiratory pathogens were detected,
had a higher rate of hospitalization (116 versus 34;
p <0.001) in contrast to patients without respiratory
pathogens, as presented in Table 2. Patients in whom
respiratory pathogens were detected were also signifi-
cantly younger (median age 6 months versus 24 months;
p <0.001), were more likely to present with feeding
problems (p <0.001), dyspnea (p = 0.004), rhinorrhea
(p <0.001), wheezing (p = 0.004) and supplemental oxygen
requirement (p = 0.009) than those in whom no respiratory
pathogen was detected. There was no difference in the
duration of hospitalization between the two groups (4.65
versus 3.96 days; p = 0.56).
Patients with one respiratory pathogen detected had a
mean hospital stay of 5.45 days in contrast to patients
with more than one respiratory pathogen who had a
mean hospital stay of 3.03 days (p = 0.024). There was no
difference in pre-existent comorbidity, premature delivery
and abnormalities on chest radiograph observed between
these two groups. In addition, patients with more than 1
respiratory pathogen were more likely to present with the
following symptoms when compared to those with 1 re-
spiratory pathogen: vomiting, feeding problems and diar-
rhea (all p < 0.001). No difference in oxygen supply or
admission to an intensive care unit was found.Figure 2 Mean Ct values of the various respiratory pathogens. Abbrev
HBoV: human bocavirus, HKU1, NL63, OC43 and 229E: human coronaviruse
influenza B virus, KIPyV: KI polyomavirus, MP: Mycoplasma pneumoniae, HPIV
HRV: human rhinovirus, RSV: respiratory syncytial virus and WUPyV: WU polIn a subgroup analysis we compared clinical and micro-
biological data of patients ≤ 3 months and those older.
There were 68 patients ≤ 3 months of age (38.4%) and 109
(61.6%) > 3 months of age. Patients ≤ 3 months of age had
a significantly higher rate (98.5 vs. 76.1%; p < 0.001) and
duration (7 vs. 3 days; p = 0.001) of hospitalization and
more frequently rhinorrhea at presentation (69.1% vs.
42.2%; p < 0.001), than patients > 3 months of age.
Patients > 3 months of age presented more often with
fever (52.9% vs. 68.8%; p = 0.034) and had a higher level of
C-reactive protein (mean 40 mg/l vs. 18 mg/l; p = 0.039)
than those ≤ 3 months of age. Four patients ≤ 3 months of
age and none of those > 3 months suffered from respira-
tory insufficiency requiring intubation and mechanical
ventilation in an intensive care unit. There was no signifi-
cant difference in detection rate of respiratory viruses
and/or M. pneumoniae between patients ≤ 3 months and
> 3 months of age (79.4% vs. 69.7%; p = 0.15). However,
multiple respiratory pathogens were more often detected
in patients ≤ 3 months (74.1% vs. 56.6%; p = 0.041).
Compared to other viruses and M. pneumoniae, the
detection of RSV was significantly associated with more
abnormalities on chest radiograph (p = 0.015) and with
more frequent observation of the following clinical
symptoms; fever (p = 0.028), feeding problems, cough,
dyspnea, rhinorrhea and wheezing (all p < 0.001). HRV
was associated with general discomfort (p = 0.021) and
rhinorrhea (p = 0.012) and HEV with fever (p = 0.045),
dyspnea (p = 0.007), rhinorrhea (p = 0.014) and wheezing
(p = 0.017). HAdV was associated with fever (p = 0.026),
HBoV with feeding problems (p = 0.032) and HCoVs
with rhinorrhea (p = 0.009).
Patients with respiratory pathogens detected, had
more frequently an antibiotic treatment prescribed byiations: Ct value: Cycle threshold value, HAdV: human adenovirus,
s, HEV: human enterovirus, HMPV: human metapneumovirus, FLUBV:
1–4: human parainfluenza viruses 1–4, HPeV: human parechovirus,
yomavirus. Horizontal bars represent group means.
Table 2 Clinical findings of patients with and without respiratory pathogens
Number of pathogens detected
0 (n = 47) ≥ 1 (n = 130) p value
Median age (months, range) 24 (0–192) 6 (0–153) 0.000
Male (%) 20 (42.6) 78 (60) 0.039
Underlying medical conditions (%) 13 (27.7) 22 (16.9) 0.113
Supplemental oxygen requirement (%) 8 (17.4) 50 (38.5) 0.009
Intensive care unit stay (%) 1 (2.1) 4 (3.1) 0.736
Mean duration of hospitalization (days) 4.0 (range 0–27) 4.7 (range 0–57) 0.565
Prematurity (%) 6 (12.8) 20 (15.4) 0.812
Abnormalities on chest radiograph (%) 11 (23.4) 31 (23.8) 0.951
Symptoms on presentation (%)
General discomfort 28 (59.6) 72 (57.1) 0.773
Feeding problems 12 (26.1) 74 (57.4) 0.000
Cough 27 (58.7) 92 (71.9) 0.099
Fever 24 (51.1) 87 (66.9) 0.054
Dyspnea 13 (27.7) 69 (53.1) 0.003
Vomiting 14 (31.1) 31 (24.2) 0.365
Rhinorrhea 13 (28.9) 77 (61.6) 0.000
Diarrhea 6 (13.3) 20 (15.7) 0.698
Wheezing 8 (17.4) 53 (41.1) 0.004
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than patients without a positive respiratory (RT)-qPCR
(p = 0.048).
Of 139 patients with the clinical diagnosis of RTI, 120
(86.3%) were diagnosed with a viral RTI and 19 (13.7%)
with a bacterial RTI. An antibiotic was prescribed to 29
(24.8%) patients with viral infection before the definite
diagnosis was made, eventually 17 patients had a positive
test result. In 10 (58.8%) of these patients detection of a
viral pathogen in the nasopharynx specimen did not re-
sult in a switch in antibiotic policy of the pediatrician.
Discussion
In this retrospective study we evaluated the diagnostic
value and the clinical relevance of detecting 19 viruses
and Mycoplasma pneumoniae in symptomatic pediatric
patients attending a pediatric outpatient clinic, emer-
gency department or admitted to the pediatric ward of a
large general hospital. At least one respiratory pathogen
was detected in 73% of the enrolled patients. These find-
ings are in support of the reports in the literature were
viral detection rates of 47-95% are described in children.
Possible explanations for the wide differences in detec-
tion rates in the literature include heterogeneity in study
populations, differences in presenting respiratory symp-
toms (upper or lower respiratory symptoms), number of
respiratory pathogens tested, method used for detection
and genetic variability between populations [1,16-18].RSV and HRV were the most common viruses detected
in this patient group, FLUAV and HPIV-2 were not
detected during the year. HPIV-2 was possibly not
detected due to a biennial cycle of HPIV-2. A plausible
explanation for the lack of detection of FLUAV is the
fact that the influenza A(H1N1)pdm09 circulated earlier
(October-December 2009) than expected and our study
was conducted in 2010 and another explanation for the
low incidence is the result of a nationwide successful
(> 95% coverage) large influenza vaccination campaign
against influenza A(H1N1)pdm09 in 2009 for children
aged between 6 months to 4 years.
Overall, in 27% of the patients, multiple respiratory
viruses were found, comparable to other studies were
the co-infection rate ranged from 17% to 41% [17,19].
As expected, the majority of the respiratory pathogens
were detected in the younger patients. The higher detec-
tion rate of respiratory pathogens among younger chil-
dren has been ascribed to a higher infection rate, lower
viral clearance rate due to a still developing specific im-
mune system against these viruses and higher infection
pressure associated with day care attendance and living
conditions such as crowding [1,2,20-22]. Furthermore,
the parents of younger children may seek healthcare
earlier in the course of disease due to parental anxiety.
The recent introduction of more sensitive molecular
methods in the clinical practice has increased the virus
detection rates significantly compared to viral culture
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positive test results more difficult, especially when mul-
tiple viruses are found with a low Ct value. Nevertheless,
the detection of a virus by RT-qPCR does not necessarily
means that it causes symptoms. The presence of a virus,
particularly HRV, has to be interpreted carefully as viral
RNA could be detected in nasal mucus for up to 5–
6 weeks after infection and respiratory viruses are also
detected in asymptomatic children [23,24]. For newer
viruses, such as WUPyV and KIPyV, causality of respira-
tory disease remains unclear. Until their role in respira-
tory disease is known inclusion in a respiratory panel for
diagnosis may not be warranted.
In literature conflicting results are reported regarding
multiple viral co-infections and its association with the
severity of acute disease. In this study, 66.6% of the HRV
positive patients HRV was co-detected with another
virus compared to 42% of the RSV cases. In addition,
most samples with more than 1 virus, HRV and RSV
were detected together, in 12 (25.5%) of the 47 samples,
respectively. Similar to our data, Aberle et al. [17] found
HRV and RSV together in 35.9% of the dual infections
and Advani et al. [24] found that in 73% of the co-
infections HRV was involved. On the other hand, Greer
et al. [25] found HRV in a much lower co-detection rate
of 23.6%. Some studies have demonstrated that multiple
viral pathogens cause more severe disease [1,17],
whereas others did not find any difference in disease se-
verity between the detection of a single and multiple re-
spiratory viruses in respiratory samples, not even with
the combination of RSV and HRV [16,19,26]. The
present findings support the latter conclusion. We found
that patients with multiple respiratory viruses even had
a shorter duration of hospitalization and were more
likely to have non-respiratory symptoms as diarrhea,
vomiting and feeding problems. This is similar to the ob-
servation of a shorter duration of hospitalization in
patients with RSV/HRV dual infections compared to
those with a single infection with RSV by others [19,27].
This suggests that HRV may have a potential protective
effect on disease severity. This may be explained by the
possible protection of the induced immune response
trigged by viral infection from infection with a second
virus as postulated by Greer et al. [25] where HRV could
protect its host from infection by other viruses.
Detection of a virus in patients with respiratory symp-
toms would be expected to aid a clinician to refrain from
the prescription and continuation of antibiotics. Unfor-
tunately, as shown by the present study this is not the
real life clinical practice as only in 40% the antibiotic
treatment was ceased. The present findings confirm pre-
vious reports that have shown that detection of a viral
respiratory pathogen in a large part of the pediatric
patients did not influence a change in antibioticmanagement of individual patients [15,28]. This may be
attributed to the young age of the children, severity of
clinical symptoms and the general attitude of clinicians
to complete antibiotic treatment in children due to con-
cern about bacterial co-infections and development of
antibiotic resistance. Identification of viral pathogens
can be of importance for both individual patient man-
agement and hospital infection control policy. Rapid
diagnosis could contribute to a significant reduction in
unnecessary laboratory tests and costly imaging, espe-
cially in young children, thereby decreasing diagnostic
costs. Bonner et al. [29] demonstrated this together with
a decreased length of time to discharge in a study were
the impact of a rapid influenza test result was deter-
mined on patient management. Rapid and sensitive diag-
nosis of viral infections is also thought to be important
to reduce nosocomial transmission as all patients
infected with a respiratory virus need to be isolated
(contact or droplet precautions). All these data suggest
that routine molecular testing for respiratory viral patho-
gens could be useful to decrease the duration of
hospitalization and reduce nosocomial infections.
In addition, in specific patient populations, e.g., after
stem cell transplantation or with immunosuppression,
identification of the viral pathogen can be important in
predicting the clinical course, preventing graft-versus-
host disease and graft rejection and, even lifesaving
[30,31].
Conclusion
In conclusion, routine testing of common respiratory
pathogens in children with ARTIs may lead to a better
understanding of the role of viral pathogens in ARTIs
and eventually to improvement of individual patient
management. However, prospective studies are required
to study the need of routinely using such tests in a gen-
eral pediatric clinic.
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